全球肢体解剖分级系统在因股腘动脉病变行腔内治疗的慢性肢体威胁性缺血患者中的评估
本研究纳入2009至2014年间在本单位因慢性肢体威胁性缺血行股腘动脉和/或胫腓动脉腔内治疗的全部309例患者,评估全球肢体解剖分级系统(GLASS)与结局的关系。结果显示GLASS分期加重与即刻技术成功显著降低相关,GLASS 3期肢体在72个月时免于再干预和免于主要不良肢体事件均显著劣于2期。作者认为GLASS可能需要进一步改进以最大化其辅助血运重建策略共同决策的价值。
要点
- GLASS分期加重与即刻技术成功显著降低相关(97.5% vs 91.5% vs 84.0%,P = .029)。
- 72个月时GLASS 3期肢体免于再干预显著劣于2期(HR 2.00,95%CI 1.11-3.57,P = .020)。
- 72个月时GLASS 3期肢体免于主要不良肢体事件显著劣于2期(HR 1.76,95%CI 1.10-2.81,P = .019)。
核心结论
- 在本研究中,GLASS 2期与3期肢体在即刻技术成功、免于再干预和免于主要不良肢体事件方面存在显著差异。
- 作者认为,若要最大化GLASS在日常临床实践中辅助血运重建策略共同决策的价值,似乎可能需要进一步改进GLASS。
研究设计与样本
- 本研究为当代病例系列,纳入2009至2014年间在本单位因慢性肢体威胁性缺血行股腘动脉和/或胫腓动脉腔内治疗尝试的全部309例患者。
- 基线特征和结局数据(包括即刻技术成功、免于截肢生存、总生存、保肢、免于再干预和免于主要不良肢体事件)来自医院数据库。
- GLASS分级和分期来自腔内治疗前血管造影影像。
- 结局数据截尾于2017年5月31日。
主要发现
- 不同GLASS股腘动脉分级、胫腓动脉分级和总体肢体分期的基线患者特征相似。
- GLASS分期加重与即刻技术成功显著降低相关(97.5% vs 91.5% vs 84.0%;P = .029)。
- 72个月时,GLASS 3期肢体的免于再干预显著劣于2期(风险比 2.00;95%置信区间 1.11-3.57;P = .020)。
- 72个月时,GLASS 3期肢体的免于主要不良肢体事件显著劣于2期(风险比 1.76;95%置信区间 1.10-2.81;P = .019)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Global Limb Anatomic Staging System (GLASS) is a new method of quantifying the anatomic severity of infrainguinal disease in patients with chronic limb-threatening ischemia. However, because GLASS has undergone limited validation, its value as an aid to shared decision-making regarding the choice of revascularization strategy remains incompletely defined. Here we report the relationship between GLASS and outcomes in a contemporary series comprising all 309 patients who underwent an attempt at femoropopliteal and/or infrapopiteal endovascular therapy for chronic limb-threatening ischemia in our unit between 2009 and 2014. METHODS: Baseline patient characteristics and outcome data including immediate technical success (ITS), amputation-free survival (AFS), overall survival, limb salvage, freedom from reintervention (FF-R), and freedom from major adverse limb events (FF-MALE) were obtained from hospital databases. GLASS grades and stage were obtained from pre-endovascular therapy angiographic imaging. Outcome data were censored on May 31, 2017. RESULTS: Baseline patient characteristics were similar across different GLASS femoropopliteal and IP grades and overall limb stages. Worsening GLASS stage was associated with a significant reduction in ITS (97.5% vs 91.5% vs 84.0%; P = .029). At 72 months FF-R (hazard ratio, 2.00; 95% confidence interval, 1.11-3.57; P = .020) and FF-MALE (hazard ratio, 1.76, 95% confidence interval, 1.10-2.81; P = .019) were significant worse in GLASS stage 3 than in stage 2 limbs. CONCLUSIONS: In our study, there were significant differences in ITS, FF-R and FF-MALE between limbs with GLASS stage 2 and 3 disease. However, further GLASS refinement seems likely to be required if its usefulness in everyday clinical practice as an aid to shared decision-making regarding the choice of revascularization strategy is to be maximized.
引用
- Meecham L, Popplewell M, Bate G, et al. Evaluation of the Global Limb Anatomic Staging System in patients with chronic limb-threatening ischemia undergoing endovascular intervention for femoropopliteal disease. J Vasc Surg. 2022. PMID: 36108823. doi:10.1016/j.jvs.2022.07.188
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。